Posted by jparsell82 on September 9, 2009, at 20:29:02
http://www.reuters.com/article/pressRelease/idUS164893+03-Sep-2009+PRN20090903
"INTUNIV, the first nonscheduled alpha-2A receptor agonist indicated for ADHD,
demonstrated improvement in a range of ADHD symptoms that can be disruptive,
such as inattention, arguing with adults, hyperactivity, impulsivity, and
losing one's temper""Once-daily INTUNIV is expected to be available in US pharmacies in November
and will come in four dosage strengths (1 mg, 2 mg, 3 mg, and 4 mg). INTUNIV
will be marketed in the United States by the existing Shire ADHD sales team of
nearly 600 representatives. INTUNIV is not a controlled substance and has no
known potential for abuse or dependence.( )"I'm curious as to how this would combine with stimulants. Anyone ever tried Guanfacine under the brand Tenex?
poster:jparsell82
thread:916261
URL: http://www.dr-bob.org/babble/neuro/20090701/msgs/916261.html